{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:02:46Z","timestamp":1788627766456,"version":"build-2803163510"},"reference-count":103,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.revmed.2023.12.008","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T18:17:49Z","timestamp":1705169869000},"page":"79-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-1352","authenticated-orcid":false,"given":"D.","family":"Farge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Allez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Castilla-Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chatelus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Faucher-Barbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Labauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Labeyrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0897-3416","authenticated-orcid":false,"given":"B.","family":"Lioure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0868-5804","authenticated-orcid":false,"given":"A.","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-3065","authenticated-orcid":false,"given":"D.","family":"Michonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5639-0138","authenticated-orcid":false,"given":"M.","family":"Puyade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Talouarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5919-9956","authenticated-orcid":false,"given":"L.","family":"Terriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Treton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wojtasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4029-2012","authenticated-orcid":false,"given":"H.","family":"Zephir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2023.12.008_bib0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nature03728","article-title":"Treatment of severe autoimmune disease by stem-cell transplantation","volume":"435","author":"Sykes","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2023.12.008_bib0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.bmt.1700727","article-title":"Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)","volume":"19","author":"Tyndall","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0015","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.patbio.2014.05.012","article-title":"[Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC]","volume":"62","author":"Farge","year":"2014","journal-title":"Pathol Biol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0025","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0030","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0035","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2018.06.025","article-title":"Systemic sclerosis as an indication for autologous hematopoietic cell transplantation: position statement from the American Society for Blood and Marrow Transplantation","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0040","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/rheumatology\/keab877","article-title":"Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus","volume":"61","author":"Goklemez","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2023.12.008_bib0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1182\/bloodadvances.2017014449","article-title":"Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis","volume":"2","author":"M","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2023.12.008_bib0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ard.2006.056630","volume":"66","author":"Daikeler","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0055","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41409-019-0763-2","article-title":"Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry","volume":"55","author":"Alexander","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0060","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/s41409-020-0907-4","volume":"55","author":"Laurent","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0065","doi-asserted-by":"crossref","first-page":"638709","DOI":"10.3389\/fimmu.2021.638709","article-title":"Autologous hematopoietic stem cell transplantation for Beh\u00e7et's disease: a retrospective survey of patients treated in Europe, on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation","volume":"12","author":"Puyade","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0070","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.bulcan.2018.11.002","volume":"106","author":"Zephir","year":"2019","journal-title":"Bull Cancer"},{"key":"10.1016\/j.revmed.2023.12.008_bib0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jamaneurol.2020.4025","article-title":"Autologous hematopoietic stem cell transplant in multiple sclerosis: recommendations of the National Multiple Sclerosis Society","volume":"78","author":"Miller","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0080","doi-asserted-by":"crossref","first-page":"556141","DOI":"10.3389\/fneur.2020.556141","volume":"11","author":"Roberts","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0085","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1007\/s00415-020-10010-6","article-title":"Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"267","author":"Burt","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0090","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s00415-021-10452-6","article-title":"Hematopoietic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: French experience about four patients, under the behalf of French society for bone marrow transplantation","volume":"268","author":"Urbain","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1352458514541978","article-title":"Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party","volume":"21","author":"Greco","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.revmed.2023.12.008_bib0100","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1212\/WNL.0000000000008394","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica","volume":"93","author":"Burt","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0105","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.3390\/ijms21155304","article-title":"Hematopoietic stem cell transplantation in neuromyelitis optica-spectrum disorders (NMO-SD): state-of-the-art and future perspectives","volume":"21","author":"Ceglie","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.revmed.2023.12.008_bib0110","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1212\/WNL.0000000000011338","article-title":"Autologous hematopoietic stem cell transplantation for stiff-person spectrum disorder: a clinical trial","volume":"96","author":"Burt","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0115","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/gutjnl-2015-309836","article-title":"Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease","volume":"65","author":"Jauregui-Amezaga","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.revmed.2023.12.008_bib0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(17)30056-0","article-title":"Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial","volume":"2","author":"Lindsay","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0125","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.bulcan.2019.11.002","article-title":"[Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]","volume":"107","author":"Puyade","year":"2020","journal-title":"Bull Cancer"},{"key":"10.1016\/j.revmed.2023.12.008_bib0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2023.12.008_bib0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","article-title":"Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system","volume":"113","author":"Alexander","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2023.12.008_bib0140","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI71691","article-title":"T cell repertoire following autologous stem cell transplantation for multiple sclerosis","volume":"124","author":"Muraro","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2023.12.008_bib0145","first-page":"107","article-title":"Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases","volume":"64","author":"Arruda","year":"2016","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.revmed.2023.12.008_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13045-016-0388-5","article-title":"Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients","volume":"10","author":"Farge","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.revmed.2023.12.008_bib0155","doi-asserted-by":"crossref","first-page":"e127655","DOI":"10.1172\/jci.insight.127655","article-title":"Extensive intrathecal T cell renewal following hematopoietic transplantation for multiple sclerosis","volume":"5","author":"Harris","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.revmed.2023.12.008_bib0160","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.bulcan.2017.06.019","article-title":"[Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]","volume":"104","author":"Pugnet","year":"2017","journal-title":"Bull Cancer"},{"issue":"12S","key":"10.1016\/j.revmed.2023.12.008_bib0165","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.bulcan.2021.03.020","article-title":"[Autologous hematopoietic cells for severe autoimmune diseases: guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) for immune monitoring and biobanking]","volume":"108","author":"Lansiaux","year":"2021","journal-title":"Bull Cancer"},{"key":"10.1016\/j.revmed.2023.12.008_bib0170","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.bulcan.2020.08.009","article-title":"[Crohn's disease and autologous hemapoietic cell transplantation: guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]","volume":"107","author":"Puyade","year":"2020","journal-title":"Bull Cancer"},{"key":"10.1016\/j.revmed.2023.12.008_bib0175","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/bloodadvances.2017010041","article-title":"Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases","volume":"1","author":"Snowden","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2023.12.008_bib0180","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0185","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/ard.2010.144360","article-title":"Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres","volume":"70","author":"Fransen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0190","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.revmed.2023.12.008_bib0200","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/annrheumdis-2016-210503","article-title":"Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)","volume":"76","author":"Herrick","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0205","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","article-title":"Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease","volume":"60","author":"Binks","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0210","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2141.2002.03895.x","article-title":"Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study","volume":"119","author":"Farge","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/ard.2007.071464","article-title":"Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis","volume":"67","author":"Vonk","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0220","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.12.008_bib0225","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs. intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2023.12.008_bib0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2023.12.008_bib0235","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2019.230128","article-title":"Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party","volume":"106","author":"Henes","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2023.12.008_bib0240","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/s41409-021-01355-1","article-title":"Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite score","volume":"56","author":"Ait Abdallah","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0245","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/kel451","article-title":"Skin involvement in scleroderma\u00a0\u2013\u00a0where histological and clinical scores meet","volume":"46","author":"Verrecchia","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0250","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3899\/jrheum.081212","article-title":"Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring","volume":"36","author":"Launay","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0255","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/rheumatology\/kez300","article-title":"Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant\u00a0\u2013\u00a0a systematic review","volume":"59","author":"Puyade","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2023.12.008_bib0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.41519","article-title":"Association of autologous hematopoietic stem cell transplantation in systemic sclerosis with marked improvement in health-related quality of life","volume":"73","author":"Maltez","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0265","doi-asserted-by":"crossref","first-page":"104065","DOI":"10.1016\/j.lpm.2021.104065","article-title":"Autologous stem cell transplantation in scleroderma","volume":"50","author":"Farge","year":"2021","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2023.12.008_bib0270","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1136\/ard.2010.148049","article-title":"Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus","volume":"70","author":"Illei","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203312470729","article-title":"Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry","volume":"22","author":"Alchi","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2023.12.008_bib0280","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0285","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/rheumatology\/35.3.248","article-title":"SLICC\/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus","volume":"35","author":"Stoll","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0290","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2023.12.008_bib0295","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","article-title":"BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus","volume":"44","author":"Isenberg","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2023.12.008_bib0300","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0305","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0310","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0315","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.msard.2015.04.006","article-title":"Is it time to target no evident disease activity (NEDA) in multiple sclerosis?","volume":"4","author":"Giovannoni","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.revmed.2023.12.008_bib0505","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41409-019-0684-0","volume":"55","author":"Sharrack","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.revmed.2023.12.008_bib0510","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2019.02.014","article-title":"Autologous hematopoietic cell transplantation for treatment-refractory relapsing multiple sclerosis: position statement from the American Society for Blood and Marrow Transplantation","volume":"25","author":"Cohen","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0320","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.revmed.2023.12.008_bib0325","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0330","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0335","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","article-title":"A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale","volume":"77","author":"Graham","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2023.12.008_bib0340","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome: Muscle Strength Assessment in GBS","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2023.12.008_bib0345","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0350","first-page":"939","article-title":"[Long-term effects of plasma exchange in myasthenia. Results of a randomized study]","volume":"12","author":"Gajdos","year":"1983","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2023.12.008_bib0355","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0360","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamaneurol.2016.0113","article-title":"Myasthenia gravis treated with autologous hematopoietic stem cell transplantation","volume":"73","author":"Bryant","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0515","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0365","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2014-309201","article-title":"Stiff-person syndrome: insights into a complex autoimmune disorder","volume":"86","author":"Baizabal-Carvallo","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2023.12.008_bib0370","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11940-009-0013-9","article-title":"Stiff person syndrome: advances in pathogenesis and therapeutic interventions","volume":"11","author":"Dalakas","year":"2009","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0375","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.revmed.2023.12.008_bib0380","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations","volume":"11","author":"Gionchetti","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0385","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.revmed.2023.12.008_bib0390","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory Bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0395","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.revmed.2023.12.008_bib0400","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1136\/gut.2005.081950b","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: current management","volume":"55","author":"Travis","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.revmed.2023.12.008_bib0405","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0410","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(89)80080-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.revmed.2023.12.008_bib0415","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.2015.16700","article-title":"Autologous hematopoetic stem cell transplantation for refractory Crohn disease: a randomized clinical trial","volume":"314","author":"Hawkey","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2023.12.008_bib0420","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ecco-jcc\/jjx180.020","article-title":"Autologous haematopoietic stem cell transplantation for Crohn's disease: a retrospective survey of long-term outcomes from the European Society for Blood and Marrow Transplantation","volume":"12","author":"Brierley","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0425","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2018.00646","volume":"9","author":"Pockley","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0430","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/s41409-020-0953-y","article-title":"A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn disease","volume":"55","author":"Burt","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0435","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bmt.2008.424","article-title":"Allogeneic hematopoietic SCT for patients with autoimmune diseases","volume":"44","author":"Daikeler","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0440","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3389\/fimmu.2019.01570","article-title":"Allogeneic HSCT for autoimmune diseases: a retrospective study from the EBMT ADWP, IEWP, and PDWP Working Parties","volume":"10","author":"Greco","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0445","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0248-8663(03)00268-6","article-title":"[Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]","volume":"25","author":"Georges","year":"2004","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2023.12.008_bib0450","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41409-021-01326-6","article-title":"Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations","volume":"56","author":"Greco","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0455","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10067-004-0942-3","article-title":"Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)","volume":"24","author":"Georges","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2023.12.008_bib0460","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2023.12.008_bib0465","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S1473-3099(16)00118-3","article-title":"Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)","volume":"16","author":"Mallet","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.revmed.2023.12.008_bib0470","series-title":"Infectious complications in patients undergoing HSCT for autoimmune diseases. Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases","author":"Burt","year":"2021"},{"key":"10.1016\/j.revmed.2023.12.008_bib0475","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41409-020-0978-2","article-title":"Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days","volume":"56","author":"Burt","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0480","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/bmt.2014.251","article-title":"SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking","volume":"50","author":"Alexander","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0485","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-020-02255-3","article-title":"Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation","volume":"22","author":"Gernert","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2023.12.008_bib0490","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","article-title":"Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party","volume":"118","author":"Daikeler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2023.12.008_bib0495","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41409-021-01277-y","article-title":"New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis","volume":"56","author":"Burt","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.revmed.2023.12.008_bib0500","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324000018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324000018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:47:22Z","timestamp":1759337242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324000018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0248866324000018"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2023.12.008","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2023.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}